Kineticos, a specialized management consulting firm serving the life science industry, today announced that it has adopted a practice area structure and expanded the service areas for its consulting organization.
“These strategic adjustments to our business improve the firm’s ability to deliver focused business services to a variety of companies across the life science industry,” stated Shailesh Maingi, CEO and Founder of Kineticos.
The Biopharmaceutical practice will assist growth-oriented pharmaceutical and biotech companies realize their commercial potential at the corporate, portfolio and product levels. Capabilities for this practice will initially focus in corporate strategy, corporate development, and commercial strategy. James Forte, Managing Director, will lead this practice.
The Biopharmaceutical Services practice will help CROs and CMOs profitably deliver differentiated value to customers as services firms look to maximize their role as powerful innovators and facilitators in the healthcare product development process. Capabilities for this practice will focus in corporate and business unit strategy, go-to-market strategy, and operational execution. Chris Church, Managing Director, will lead this practice.
The Diagnostics practice will help diagnostic companies—including labs and tools companies—successfully navigate the market and grow. Capabilities for this practice will focus in corporate and go-to-market strategy, corporate development, and operational execution. Bill Finger, Managing Director, will lead this practice.
Mr. Maingi continued, “We view the industry as an evolving ecosystem. As a management consulting firm with unique knowledge and experience across the ecosystem, Kineticos—through its three practice areas—is ideally positioned to help companies thrive.”
For more information about Kineticos, its practices and their capabilities, please visit www.kineticos.com/life-science-consulting-firm/.